Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis Subjects”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00794807
What this trial is testing

Safety and Tolerability of Repeat Courses of IM Alefacept

Who this might be right for
Chronic Plaque Psoriasis
Charite University, Berlin, Germany 20
Large-scale testing (Phase 3)Study completedNCT03123471
What this trial is testing

The Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp

Who this might be right for
Psoriasis
Amgen 303
Large-scale testing (Phase 3)Study completedNCT00195676
What this trial is testing

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 1,469
Testing effectiveness (Phase 2)WithdrawnNCT02970331
What this trial is testing

A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis

Who this might be right for
Psoriasis
Maruho Co., Ltd.
Large-scale testing (Phase 3)UnknownNCT03927352
What this trial is testing

The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis

Who this might be right for
Psoriasis
Sinocelltech Ltd. 330
Early research (Phase 1)Study completedNCT01563068
What this trial is testing

Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis

Who this might be right for
Psoriasis
Mayne Pharma International Pty Ltd 18
Large-scale testing (Phase 3)Study completedNCT02982005
What this trial is testing

KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea

Who this might be right for
Moderate to Severe Plaque Psoriasis
Kyowa Kirin Korea Co., Ltd. 62
Large-scale testing (Phase 3)Study completedNCT02826603
What this trial is testing

Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 1,114
Large-scale testing (Phase 3)Study completedNCT01001208
What this trial is testing

The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis

Who this might be right for
Psoriasis
Amgen 478
Large-scale testing (Phase 3)Study completedNCT01241591
What this trial is testing

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 1,101
Large-scale testing (Phase 3)Study completedNCT03875482
What this trial is testing

Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 157
Testing effectiveness (Phase 2)Ended earlyNCT00782613
What this trial is testing

Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Synvista Therapeutics, Inc 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07543224
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

Who this might be right for
Plaque Psoriasis Subjects
Reistone Biopharma Company Limited 600
Early research (Phase 1)Ended earlyNCT02502188
What this trial is testing

Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
ParapsoriasisHealthy Volunteers
Celgene 24
Post-approval studies (Phase 4)Study completedNCT00735787
What this trial is testing

Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet

Who this might be right for
Psoriasis
Abbott 81
Large-scale testing (Phase 3)Study completedNCT00710580
What this trial is testing

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 350
Large-scale testing (Phase 3)Study completedNCT04761627
What this trial is testing

Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 494
Large-scale testing (Phase 3)Study completedNCT03759197
What this trial is testing

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Therapeutics, Inc. 206
Large-scale testing (Phase 3)Study completedNCT00338754
What this trial is testing

Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 160
Testing effectiveness (Phase 2)Study completedNCT00606450
What this trial is testing

Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Amgen 260
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation